Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration

Pharmacokinetics of Doripenem in Infected Patients Treated Within and Outside the Intensive Care Unit

(2013) Amira A Bhalodi et al.   ANNALS OF PHARMACOTHERAPY

Population Pharmacokinetics of Piperacillin at Two Dose Levels: Influence of Nonlinear Pharmacokinetics on the Pharmacodynamic Profile

(2012) Cornelia B. Landersdorfer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Fusidic Acid: Rationale for Front-Loaded Dosing Regimens Due to Autoinhibition of Clearance

(2012) Jürgen B. Bulitta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pseudomonas aeruginosa is not just in the intensive care unit any more

(2012) Kathryn J. Eagye et al.   CRITICAL CARE MEDICINE

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy

(2012) Darren M. Roberts et al.   CRITICAL CARE MEDICINE

Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility*

(2012) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Improving antibiotic dosing in special situations in the ICU

(2012) Janattul-Ain Jamal et al.   Current Opinion in Critical Care

Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study

(2012) Pattarachai Kiratisin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance

(2012) Andrew A. Udy et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia

(2012) Sutep Jaruratanasirikul et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Development of a New Pre- and Post-Processing Tool (SADAPT-TRAN) for Nonlinear Mixed-Effects Modeling in S-ADAPT

(2011) Jurgen Bernd Bulitta et al.   AAPS Journal

Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem

(2011) Iolanda Cirillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Single-Dose Doripenem in Adults With Cystic Fibrosis

(2011) Iolanda Cirillo et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effect of Hemopurification Rate on Doripenem Pharmacokinetics in Critically Ill Patients Receiving High-flow Continuous Hemodiafiltration

(2011) Yoshifumi OHCHI et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients

(2010) P. Nandy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nonlinear pharmacokinetics of piperacillin in healthy volunteers - implications for optimal dosage regimens

(2010) Jürgen B. Bulitta et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Doripenem Pharmacokinetics in Critically Ill Patients Receiving Continuous Hemodiafiltration (CHDF)

(2010) Seigo HIDAKA et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Doripenem

(2009) David L. Paterson et al.   CLINICAL INFECTIOUS DISEASES

Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

(2009) Leonardo Lorente et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Disposition, Metabolism, and Excretion of [14C]Doripenem after a Single 500-Milligram Intravenous Infusion in Healthy Men

(2008) I. Cirillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS